Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (36,302)	$ (23,858)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	215	152
Shares issued as compensation for consulting services		38
Stock-based compensation	6,706	2,512
Loss on fair value adjustment of warrant liability	294	1,124
Gain on fair value of strategic investments	(276)	(1,196)
Accretion and interest related to marketable securities	(3,181)
Loss on debt extinguishment		682
Non-cash lease expense	473	419
Amortization of deferred financing fees	109	127
Changes in operating assets and liabilities:
Accounts receivable	10	25
Inventory	139	(262)
Prepaid expenses and other assets	(458)	(475)
Accounts payable, accrued expenses and other liabilities	(348)	2,294
Operating lease liabilities - current and non-current	(516)	(196)
Deferred revenue	(2,018)	(1,931)
Net cash used in operating activities	(35,153)	(20,545)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(81)	(537)
Sales of marketable securities	115,690
Purchases of marketable securities	(138,073)	(208)
Net cash used in investing activities	(22,464)	(745)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of debt financing, inclusive of debt extinguishment costs		(6,446)
Proceeds from Avenue term loan		10,000
Proceeds from exercise of warrants	23	79
Proceeds from exercise of stock options	78	121
Effect of merger, net of transaction costs (Note 3)	56,810
Proceeds from private placement financing		109,830
Deferred financing, offering and merger costs		(5,237)
Net cash provided by financing activities	56,911	108,347
Net (decrease) increase in cash and cash equivalents	(706)	87,057
Cash and cash equivalents, beginning of the period	19,784	9,938
Cash and cash equivalents, end of the period	19,078	96,995
Cash paid during the nine months ended September 30:
Interest	$ 1,098	1,040
Non-cash financing activities:
Deferred offering and merger costs in accounts payable and accrued expenses		5,682
Warrants issued pursuant to private placement financing		620
Warrants issued pursuant to debt financing		$ 178